HLA haploidentical peripheral blood mononuclear cell infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HLA haploidentical peripheral blood mononuclear cell infusion, covering 2016-02-25 to 2016-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML) [Phase 1, Phase 2]